Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE-therapeutics Share News (ETX)

Share Price Information for E-therapeutics (ETX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.50
Bid: 9.30
Ask: 9.50
Change: -0.35 (-3.59%)
Spread: 0.20 (2.151%)
Open: 9.55
High: 10.00
Low: 9.50
Prev. Close: 9.75
ETX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: F&C Investment Trust hires CBI chief economist

Mon, 29th Mar 2021 15:13

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

F&C Investment Trust PLC - aims for long-term growth and income by investing in listed equities globally - Appoints Rain Newton-Smith as independent non-executive director, starting May 11. Newton-Smith will replace Roger Bone, who is retiring. She is chief economist at the Confederation of British Industry. Previous to the CBI, she was head of Emerging Markets at Oxford Economics. FTSE 250-listed F&C Investment Trust bills itself as the world's oldest collective investment scheme, having launched in 1868.

----------

Spirent Communications PLC - Crawley, England-based provider of testing, analytics and security for telecommunications networks - Appoints Maggie Buggie as non-executive director with effect on April 29. Buggie is currently chief business offer at SAP Services, which is part of Walldorf, Germany-based enterprise software developer SAP SE.

----------

Vesuvius PLC - London-based molten metal flow engineering - Hires Dinggui Gao as non-executive director, starting on Thursday. He currently is managing director of China for Formel D Group, a German service provider to the automotive and components supply industry.

----------

e-Therapeutics PLC - Oxford, England-based computer-based drug discovery - Hires Karl Keegan as chief financial officer, effective immediately. Keegan was most recently chief executive officer of privately held Hox Therapeutics Ltd.

----------

Okyo Pharma Ltd - London-based biotechnology company focused on treatments of inflammatory dry eye diseases and ocular pain - Hires Rajkumar Patil as chief scientific officer. Says Patil has 30 years of ophthalmic and pharmaceutical research and development experience, including with Ora Inc and iVeena Delivery Systems. He also worked at the Alcon/Novartis Institute of Biomedical Research.

----------

Serinus Energy PLC - oil and gas exploration and production in Tunisia and Romania - Dawid Jakubowicz resigns immediately from board, while Eleanor Barke won't stand for re-election to the board at the May 13 annual general meeting. In their place, Serinus hires Natalie Fortescue and Jon Kempster. Fortescue was an investment banker at Investec and Oriel Securities. She joined Genel Energy PLC to establish the investor relations department and also worked with Premier Oil PLC on its reverse takeover by Chrysaor Energy Ltd. Kempster has held CFO positions at companies including London listings Frasers Group PLC and Wincanton PLC, and he currently is interim CFO of FireAngel Safety Technology Group PLC. Kempster also currently is a non-executive director of Bonhill Group PLC, Redcentric PLC and Ted Baker PLC.

----------

Fragrant Prosperity Holdings Ltd - seeking acquisition in cannabis therapeutics - Hires Daniel Reshef as non-executive director starting on Wednesday. Reshef has had a 25-year career in drug development, including with Hoffman La Roche, Genentech and Bristol Myers Squibb Co.

----------

French Connection Group PLC - London-based fashion retailer - Hires Neil Page as independent non-executive director. Page was CFO of retailer Carpetright PLC. French Connection entered a formal sales process at the beginning of month after receiving two separate takeover approaches.

----------

Braveheart Investment Group PLC - makes strategic investments in companies it thinks will outperform - Jonathan Freeman steps down as non-executive director "to devote more time to his other business interests". Starts process for finding a new non-executive director.

----------

Arix Bioscience PLC - venture capital investor in biotech companies - Pauses hire of James Noble and Axel Wieandt as non-executive directors, citing recently announced strategic review, which encompasses board composition.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
29 Oct 2019 18:49

Invesco's Holding In e-Therapeutics Drops To Zero From 32%

Invesco's Holding In e-Therapeutics Drops To Zero From 32%

Read more
7 Oct 2019 09:14

e-therapeutics Loss Narrows On Lower Costs, Collaboration Income

e-therapeutics Loss Narrows On Lower Costs, Collaboration Income

Read more
7 Oct 2019 09:13

e-therapeutics Loss Narrows On Lower Costs, New Collaboration Income

e-therapeutics Loss Narrows On Lower Costs, New Collaboration Income

Read more
13 Aug 2019 12:16

e-Therapeutics Partners With Pharma Firm For Drug Discovery

(Alliance News) - e-Therapeutics PLC on Tuesday said it has agreed to work with an undisclosed global pharmaceutical company, on a project in a specific area of biology, associated with occurs is

Read more
10 Jun 2019 13:33

Woodford Raises GBP500 Million From Flurry Of London Share Sales (ALLISS)

LONDON (Alliance News) - Over the past week, fund manager Neil Woodford's Woodford Investment Management has conducted a fire sale of its stakes in 20 London-listed companies - raising in of -

Read more
5 Mar 2019 11:50

e-Therapeutics Annual Loss Narrows Amid Reduced Research Costs

LONDON (Alliance News) - e-Therapeutics PLC on Tuesday said its annual loss narrowed as research and development costs were significantly cut.For the year ended January, the drug discovery

Read more
26 Feb 2019 16:08

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 27 February ITVFull Year ResultsRio TintoFull Year Results (at 0600 James's

Read more
10 Dec 2018 14:30

E-Therapeutics launches research collaboration with Novo Nordisk

(Sharecast News) - E-Therapeutics announced a research collaboration with Novo Nordisk on Monday, under which the two companies would use e-Therapeutics' proprietary 'Network-Driven Drug Discovery' (NDD) platform to look to discover potentially novel biological mechanisms and therapeutic approaches for a specific area of type-2 diabetes.

Read more
6 Dec 2018 16:04

E-Therapeutics and C4X upbeat on Parkinson's collaboration

(Sharecast News) - Network-driven drug discovery company e-Therapeutics and C4X Discovery Holdings updated the market on their collaboration on Thursday, to identify novel intervention strategies for the potential treatment of Parkinson's Disease (PD).

Read more
6 Dec 2018 09:23

e-Therapeutics And C4X Identify New Pathways For Parkinson's Treatment

LONDON (Alliance News) - C4X Discovery Holdings PLC and e-Therapeutics PLC on Thursday said that, through their collaboration, they discovered additional novel biological pathways for the of that

Read more
4 Oct 2018 11:08

e-Therapeutics narrows interim losses as it eyes commercial viability

(Sharecast News) - Half-year losses at e-Therapeutics have narrowed as the drug discovery and development firm continued to manage costs.

Read more
4 Oct 2018 10:31

e-Therapeutics Interim Loss Narrows As It "Carefully" Manages Costs

LONDON (Alliance News) - e-Therapeutics PLC said Thursday that its half-year loss narrowed as it continued to effectively and "carefully" manage its costs.For the six months ended

Read more
27 Sep 2018 16:16

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 28 September United UtilitiesTrading Statement Baillie Gifford Shin Year 1 events 2 3

Read more
24 May 2018 16:10

UK Shareholder Meetings Calendar - Next 7 Days

Friday 25 MayHochschild MiningFerrexpoKeywords Mutual (re managed 28 events 29 Stobart Life (re of

Read more
1 May 2018 11:41

e-Therapeutics Pens Research Collaboration With C4X Discovery

LONDON (Alliance News) - e-Therapeutics PLC and C4X Discovery Holdings PLC on Tuesday announced a research collaboration to look into insights into Parkinson's disease.The partnership,

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.